{"id":"NCT02314117","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01-20","primaryCompletion":"2017-01-17","completion":"2020-08-14","firstPosted":"2014-12-10","resultsPosted":"2018-05-02","lastUpdate":"2021-08-26"},"enrollment":645,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Gastric Adenocarcinoma","Gastroesophageal Junction Adenocarcinoma"],"interventions":[{"type":"DRUG","name":"Ramucirumab","otherNames":["LY3009806","IMC-1121B","Cyramza"]},{"type":"DRUG","name":"Capecitabine","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Fluorouracil","otherNames":[]}],"arms":[{"label":"Ramucirumab + Cisplatin + Capecitabine","type":"EXPERIMENTAL"},{"label":"Placebo + Cisplatin + Capecitabine","type":"ACTIVE_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate the efficacy of ramucirumab, which is a targeted antibody, in combination with capecitabine and cisplatin compared to capecitabine and cisplatin alone in participants with stomach cancer.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"Randomization to Radiological Disease Progression or Death from Any Cause (Up to 26 Months)","effectByArm":[{"arm":"Ramucirumab + Cisplatin + Capecitabine","deltaMin":5.72,"sd":null},{"arm":"Placebo + Cisplatin + Capecitabine","deltaMin":5.39,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":135,"countries":["United States","Argentina","Belgium","Canada","Czechia","Denmark","Finland","France","Germany","Hungary","Israel","Italy","Japan","Mexico","Netherlands","Poland","Puerto Rico","Russia","Spain","United Kingdom"]},"refs":{"pmids":["34795131","30718072"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/kPN4NxC5uCCu4eG6MMGeI?conditionId=B6nAiYh98OCsos8uoOISQ"]},"adverseEventsSummary":{"seriousAny":{"events":161,"n":323},"commonTop":["Nausea","Fatigue","Vomiting","Decreased appetite","Anaemia"]}}